Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma
PHASE2CompletedINTERVENTIONAL
Enrollment
22
Participants
Timeline
Start Date
November 30, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2017
Conditions
Mesothelioma, Malignant
Interventions
DRUG
Gemcitabine
infusion drug
DRUG
Imatinib mesylate
oral drug
Trial Locations (1)
20089
Istituto Clinico Humanitas, Rozzano
All Listed Sponsors
lead
Istituto Clinico Humanitas
OTHER
NCT02303899 - Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma | Biotech Hunter | Biotech Hunter